Explore the Global Targeted Oncology Biologics Market— analysis of key trends, regional growth, top players, and a 10-year forecast from 2026 to 2036.

Future Market Insights

Targeted Oncology Biologics Market

Key Insight

The targeted oncology biologics market is projected to grow from USD 74,751.0 million in 2026 to USD 186,948.7 million by 2036, at a CAGR of 9.6%. Monoclonal antibodies will dominate with a 46.0% market share, while breast cancer will lead the applications segment with a 28.0% share.

January 12, 2026

Anurag Sharma

250 Pages

Cite this Report

Targeted Oncology Biologics Market

https://www.futuremarketinsights.com/reports/targeted-oncology-biologics-market

License

Starting at US$ 5000

Buy Now

Summary ToC Infographics Companies

Key Players

Amgen
BlackRock
BMS Group Ltd
The Vanguard Group
Roche

Methodology

Member of

Greater New York Chamber of Commerce

Recognized by

Awarded by

SILVER STEVIE® WINNER

Asia Pacific Stevie Awards - 2023

BRONZE STEVIE® Award

20th annual IBAs

Quick Contact

Chat on Whatsapp + 44 20 3769 9709 + 1 347 918 3531 Contact By Email

Get Free Sample PDF

Targeted Oncology Biologics Market

Key Players

Similar Industry Reports